Trastuzumab-canmab (150 mg & 440 mg)

Biocon

“Trastuzumab” is the Drug / Molecule content in “Canmab”. Trastuzumab is a monoclonal antibody that interferes with the HER2/neu receptor. It works by targeting certain tumour cells and stopping them from growing and reproducing.These antibodies interferes with the HER2/neu receptor protein that are embedded in the cell membrane and communicate molecular signals from outside the cell (molecules called EGFs) to inside the cell, and turn genes on and off.

Category:

Indication

Canmab has used for the treatment of Metastatic Breast Cancer  and / or stomach cancer.

Note

Precaution

  • Canmab is a prescription drug and should be used under proper medical guidance
  • Canmab might harm a baby developing in the womb. It is important not to become pregnant or father a child while you are having treatment and for 7 months afterwards.

Related products